Manchester Capital Management LLC Collegium Pharmaceutical, Inc Transaction History

Manchester Capital Management LLC

  • $814 Million
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022
SELL
$17.5 - $21.35 $1.22 Million - $1.48 Million
-69,535 Closed
0 $0
Q4 2019

Feb 10, 2020
BUY
$10.7 - $22.24 $290,034 - $602,837
27,106 Added 63.89%
69,535 $1.43 Million
Q1 2019

May 08, 2019
BUY
$13.58 - $18.72 $128,045 - $176,510
9,429 Added 28.57%
42,429 $642,000
Q1 2018

May 07, 2018
BUY
$18.15 - $29.21 $256,695 - $413,117
14,143 Added 75.0%
33,000 $843,000
Q4 2017

Feb 08, 2018
BUY
$9.3 - $19.14 $175,370 - $360,922
18,857
18,857 $348,000

Others Institutions Holding COLL

# of Institutions
236
Shares Held
39.4M
Call Options Held
84.2K
Put Options Held
18.6K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.31B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Manchester Capital Management LLC Portfolio

Follow Manchester Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manchester Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manchester Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email